menu
Stem cell therapy products for the treatment of a variety of disease indications
Stem cell therapy products for the treatment of a variety of disease indications
There is a growing body of evidence supporting the vast applicability and superiority of treatment outcomes of stem cell therapies, compared to conventional treatment options.

To order this 500+ page report, which features 185+ figuresand 220+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/stem-cells-market/296.html

 

The USD 8.5 billion (by 2030) financial opportunitywithin the stem cell therapies market has been analyzed across the followingsegments:

§  Sourceof stem cell

§  Allogeneic

§  Autologous

 

§  Originof stem cell

§  Adult

§  Embryonic

 

§ Type of stem cell

§  Hematopoietic

§  Mesenchymal

§  Progenitor

§  Others

 

§  Lineageof stem cell

§  AdiposeTissue

§  BoneMarrow

§  CordBlood

§  Others

 

§  Routeof Administration

§  Intraarticular

§  Intracoronary

§  Intramuscular

§  Intramyocardial

§  Intrathecal

§  Intravenous

§  SurgicalImplantations

§  Others

 

§  TherapeuticArea

§  Autoimmune/ Inflammatory Disorder

§  CardiovascularDisorders

§  MetabolicDisorder

§  MusculoskeletalDisorders

§  OncologicalDisorders

§  NeurologicalDisorders

§  OphthalmicDisorders

§  Others

 

§  EndUsers

§  AmbulatorySurgery Centers

§  Hospitals

§  SpecialtyClinics

 

§  KeyGeographies

§  NorthAmerica

§  Europe

§  Asia-Pacificand Rest of the World

 

The Global Stem CellsMarket:Focus on Clinical Therapies, 2020–2030 (Based on Source (Allogeneic,Autologous); Origin (Adult, Embryonic); Type (Hematopoietic, Mesenchymal,Progenitor); Lineage (Amniotic Fluid, Adipose Tissue, Bone Marrow,Cardiosphere, Chondrocytes, Corneal Tissue, Cord Blood, Dental Pulp, NeuralTissue Placenta, Peripheral Blood, Stromal Cells); and Potency (Multipotent,Pluripotent))”. report features thefollowing companies, which we identified to be key players in this domain:

§ Anterogen

§ Athersys

§ CHABiotech

§ Cytopeutics

§ Hope Biosciences

§ Japan Regenerative Medicine

§ Lineage Cell Therapeutics

§ Orchard Therapeutics

§ Osiris Therapeutics

§ Pluristem Therapeutics

§ Promithera Biosciences

§ Regenexx

§ Stempeutics Research

§ SCM Life Sciences

§  TICEBA

 

Table of Contents

 

1. Preface

2. Executive Summary


3. Introduction

4. Market Landscape

5. Company Profiles

6. Key Therapeutic Areas

7. Assessment of Relative Competition and GrowthOpportunities 

8. Academic Grants Analysis

9. Clinical Trail Analysis

10. Stem Cell Manufacturing Market Landscape and KPIsfor Evaluating Contract

Services Partners

11. Stem Cell Therapy Developers and CMOs: OpportunityAssessment

12. Key Commercialization Strategies

 

13. Market Forecast

14. Conclusion

15. Executive Insights

 

16. Appendix 1: Tabulated Data

 

17. Appendix 2: List of Companies and Organizations

 

 

To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/stem-cells-market/296.html/

 

Contact Details

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@rootsanalysis.com